3,600 research outputs found

    Limitations of the Millennium Development Goals: a literature review

    Get PDF
    With the Millennium Development Goals (MDGs) showing uneven progress, this review identifies possible limitations arising from the MDG framework itself rather than extrinsic issues. A multidisciplinary literature review was conducted with a focus on limitations in the formulation of the MDGs, their structure, content and implementation. Of 1837 MDG-related articles, 90 met criteria for analysis. Articles describe MDGs as being created by only a few stakeholders without adequate involvement by developing countries and overlooking development objectives previously agreed upon. Others claim MDGs are unachievable and simplistic, not adapted to national needs, do not specify accountable parties and reinforce vertical interventions. While MDGs have promoted increased health and well-being in many countries by recognising and deliberating on the possible constraints of the MDG framework, the post-2015 agenda may have even greater impact. Complex problems have simple, easy to understand, wrong answers (Henry Louis Mencken

    Neutron radiography for visualization of liquid metal processes: Bubbly flow for CO2 free production of Hydrogen and solidification processes in em field

    Get PDF
    The paper describes the results of two experimental investigations aimed to extend the abilities of a neutron radiography to visualize two-phase processes in the electromagnetically (EM) driven melt flow. In the first experiment the Argon bubbly flow in the molten Gallium - a simulation of the CO2 free production of Hydrogen process - was investigated and visualized. Abilities of EM stirring for control on the bubbles residence time in the melt were tested. The second experiment was directed to visualization of a solidification front formation under the influence of EM field. On the basis of the neutron shadow pictures the form of growing ingot, influenced by turbulent flows, was considered. In the both cases rotating permanent magnets were agitating the melt flow. The experimental results have shown that the neutron radiography can be successfully employed for obtaining the visual information about the described processes.LIMTEC

    Vascular Changes Following Exercise-Induced Hyperthermia

    Get PDF
    Please view abstract in the attached PDF file

    Simultaneous observation of high order multiple quantum coherences at ultralow magnetic fields

    Full text link
    We present a method for the simultaneous observation of heteronuclear multi-quantum coherences (up to the 3rd order), which give an additional degree of freedom for ultralow magnetic field (ULF) MR experiments, where the chemical shift is negligible. The nonequilibrium spin state is generated by Signal Amplification By Reversible Exchange (SABRE) and detected at ULF with SQUID-based NMR. We compare the results obtained by the heteronuclei Correlated SpectroscopY (COSY) with a Flip Angle FOurier Series (FAFOS) method. COSY allows a quantitative analysis of homo- and heteronuclei quantum coherences

    A comparison framework and review of service brokerage solutions for cloud architectures

    Get PDF
    Cloud service brokerage has been identified as a key concern for future cloud technology development and research. We compare service brokerage solutions. A range of specific concerns like architecture, programming and quality will be looked at. We apply a 2-pronged classification and comparison framework.We will identify challenges and wider research objectives based on an identification of cloud broker architecture concerns and technical requirements for service brokerage solutions. We will discuss complex cloud architecture concerns such as commoditisation and federation of integrated, vertical cloud stacks

    The deal.II Library, Version 9.1

    Get PDF
    This paper provides an overview of the new features of the finite element library deal.II, version 9.1

    Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies

    Get PDF
    Background Enthesitis is one of the psoriatic arthritis (PsA) domains. Patients with enthesitis are associated with worse outcomes than those without enthesitis. The effect of secukinumab on the resolution of enthesitis in patients with PsA was explored using pooled data from the FUTURE 2 and 3 studies. Method Assessments of enthesitis through week 104 used the Leeds Enthesitis Index. These post hoc analyses included resolution of enthesitis count (EC = 0), median time to first resolution of enthesitis (Kaplan-Meϊer estimate), and shift analysis (as observed) of baseline EC (1, 2, or 3–6) to full resolution (FR), stable (similar or reduction of EC), or worse (EC > baseline). Efficacy outcomes (ACR, PASI, HAQ-DI, SF-36 PCS, and DAS28-CRP) were assessed in patients with or without baseline enthesitis. Results are reported for secukinumab 300 and 150 mg in the overall population and by prior TNFi treatment. Results A total of 65% (466/712) of patients had baseline enthesitis. In the overall population, FR was achieved as early as week 16 in 65% (300 mg) and 56% (150 mg) versus 44% (placebo) patients, with further improvements to 91% (300 mg) and 88% (150 mg) at week 104. The majority (89%) of patients without enthesitis at baseline maintained this status at week 104. Median days to resolution of EC were shorter with secukinumab 300 and 150 mg versus placebo (57 and 85 vs 167 days, respectively). In patients with EC of 1 or 2, shift analysis from baseline to week 24 showed that more patients achieved FR with secukinumab 300 mg and 150 mg versus placebo, whereas no difference between secukinumab and placebo was shown in the more severe patients with EC of 3–6. Increases in proportions of patients with FR were observed with secukinumab irrespective of the severity of EC from baseline to week 104. Improvements in efficacy outcomes were similar in patients with or without enthesitis treated with secukinumab 300 mg. Conclusion Secukinumab provided early and sustained resolution of enthesitis in patients with PsA over 2 years. Secukinumab 300 mg provided higher resolution than 150 mg in patients with more severe baseline EC and showed similar overall efficacy in patients with or without enthesitis. Trial registration FUTURE 2: ClinicalTrials.gov, NCT01752634 (date of study registration: December 19, 2012), and EudraCT, 2012-004439-22 (date of study registration: December 12, 2012) FUTURE 3: ClinicalTrials.gov, NCT01989468 (date of study registration: November 21, 2013), and EudraCT, 2013-004002-25 (date of study registration: December 17, 2013
    corecore